These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10855788)

  • 1. Monoclonal antibody therapy of human gliomas: current status and future approaches.
    Wikstrand CJ; Cokgor I; Sampson JH; Bigner DD
    Cancer Metastasis Rev; 1999; 18(4):451-64. PubMed ID: 10855788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monoclonal immunotherapy with human monoclonal antibody(CLN-IgG) in glioma patients].
    Kubo O; Takakura K
    Nihon Rinsho; 2002 Mar; 60(3):497-503. PubMed ID: 11904965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspects of immunobiology and immunotherapy and uses of monoclonal antibodies and biologic immune modifiers in human gliomas.
    Lee Y; Bigner DD
    Neurol Clin; 1985 Nov; 3(4):901-17. PubMed ID: 2417097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma.
    Everson RG; Graner MW; Gromeier M; Vredenburgh JJ; Desjardins A; Reardon DA; Friedman HS; Friedman AH; Bigner DD; Sampson JH
    Expert Rev Anticancer Ther; 2008 May; 8(5):717-32. PubMed ID: 18471045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trial of targeting therapy against malignant glioma using monoclonal antibody.
    Takahashi H; Teramoto A
    J Nippon Med Sch; 2004 Feb; 71(1):2-3. PubMed ID: 15129587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-based immunotherapy for malignant glioma.
    Gedeon PC; Riccione KA; Fecci PE; Sampson JH
    Semin Oncol; 2014 Aug; 41(4):496-510. PubMed ID: 25173142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-TA226 human monoclonal antibody (ACA-11) against glioma].
    Kokunai T
    Nihon Rinsho; 2002 Jan; 60(1):100-6. PubMed ID: 11808318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunobiology of brain tumors.
    Sawamura Y; de Tribolet N
    Adv Tech Stand Neurosurg; 1990; 17():3-64. PubMed ID: 2180410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging monoclonal antibody therapies for malignant gliomas.
    Gerber DE; Laterra J
    Expert Opin Investig Drugs; 2007 Apr; 16(4):477-94. PubMed ID: 17371196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular immunotherapy for malignant gliomas.
    Lin Y; Okada H
    Expert Opin Biol Ther; 2016 Oct; 16(10):1265-75. PubMed ID: 27434205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies in neuro-oncology.
    Stavrou D
    Neurosurg Rev; 1990; 13(1):7-18. PubMed ID: 2181345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prospects for targeted therapy for gliomas].
    Chekhonin VP; Baklaushev VP; Iusubalieva GM
    Vestn Ross Akad Med Nauk; 2009; (4):30-42. PubMed ID: 19514310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pritumumab, the first therapeutic antibody for glioma patients.
    Babic I; Nurmemmedov E; Yenugonda VM; Juarez T; Nomura N; Pingle SC; Glassy MC; Kesari S
    Hum Antibodies; 2018 Feb; 26(2):95-101. PubMed ID: 29036806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor expression in human malignant glioma: in vitro and in vivo effects of application of monoclonal antibodies to the epidermal growth factor receptor.
    Westphal M; Hamel W; Zirkel D; Herrmann HD; Bilzer T; Reifenberger G; Schober R; Wechsler W; Albert FK; Behnke J
    Recent Results Cancer Res; 1994; 135():171-84. PubMed ID: 8047692
    [No Abstract]   [Full Text] [Related]  

  • 15. A phase I study of an anti-epidermal growth factor receptor monoclonal antibody for the treatment of malignant gliomas.
    Faillot T; Magdelénat H; Mady E; Stasiecki P; Fohanno D; Gropp P; Poisson M; Delattre JY
    Neurosurgery; 1996 Sep; 39(3):478-83. PubMed ID: 8875477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New perspectives in glioma immunotherapy.
    Daga A; Bottino C; Castriconi R; Gangemi R; Ferrini S
    Curr Pharm Des; 2011; 17(23):2439-67. PubMed ID: 21827420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma.
    Deng S; Zhu S; Qiao Y; Liu YJ; Chen W; Zhao G; Chen J
    Protein Cell; 2014 Dec; 5(12):899-911. PubMed ID: 25411122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor antigens in astrocytic gliomas.
    Kurpad SN; Zhao XG; Wikstrand CJ; Batra SK; McLendon RE; Bigner DD
    Glia; 1995 Nov; 15(3):244-56. PubMed ID: 8586461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive antibody-mediated immunotherapy for the treatment of malignant gliomas.
    Mitra S; Li G; Harsh GR
    Neurosurg Clin N Am; 2010 Jan; 21(1):67-76. PubMed ID: 19944967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies: prospects for specific immunotherapy for gliomas.
    Nowak TP
    Am J Clin Oncol; 1987 Aug; 10(4):278-80. PubMed ID: 3113229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.